CVS Health Corp (N:CVS)

Business Focus: Healthcare Facilities & Services

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for CVS within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET February 19th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Feb 19/20 Feb 18/20 Lynch Karen S Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -14,215  
Feb 14/20 Feb 14/20 Weldon William C Direct Ownership Common Stock Form 5 : Annual Statement of Beneficial Ownership of Securities    
Jan 17/20 Jan 15/20 Merlo Larry J Direct Ownership Stock Option M - Exercise or conversion exempt under rule 16b-3 -314,713  
Jan 17/20 Jan 15/20 Merlo Larry J Direct Ownership Common Stock S - Open market or private sale -266,476 $74.79
Jan 17/20 Jan 15/20 Merlo Larry J Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 314,713 $54.53
Jan 10/20 Jan 8/20 Roberts Jonathan C Direct Ownership Stock Option M - Exercise or conversion exempt under rule 16b-3 -68,844  
Jan 10/20 Jan 8/20 Roberts Jonathan C Direct Ownership Common Stock S - Open market or private sale -57,563 $72.63
Jan 10/20 Jan 8/20 Roberts Jonathan C Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 68,844 $54.53
Dec 4/19 Dec 2/19 Lynch Karen S Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -12,778 $75.55
Nov 22/19 Nov 20/19 White Tony L Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 1,551 $74.92
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for CVS within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET February 19th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Feb 19/20 Feb 18/20 Lynch Karen S Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -14,215  
Feb 14/20 Feb 14/20 Weldon William C Direct Ownership Common Stock Form 5 : Annual Statement of Beneficial Ownership of Securities    
Jan 17/20 Jan 15/20 Merlo Larry J Direct Ownership Stock Option M - Exercise or conversion exempt under rule 16b-3 -314,713  
Jan 17/20 Jan 15/20 Merlo Larry J Direct Ownership Common Stock S - Open market or private sale -266,476 $74.79
Jan 17/20 Jan 15/20 Merlo Larry J Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 314,713 $54.53
Jan 10/20 Jan 8/20 Roberts Jonathan C Direct Ownership Stock Option M - Exercise or conversion exempt under rule 16b-3 -68,844  
Jan 10/20 Jan 8/20 Roberts Jonathan C Direct Ownership Common Stock S - Open market or private sale -57,563 $72.63
Jan 10/20 Jan 8/20 Roberts Jonathan C Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 68,844 $54.53
Dec 4/19 Dec 2/19 Lynch Karen S Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -12,778 $75.55
Nov 22/19 Nov 20/19 White Tony L Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 1,551 $74.92
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $CVS

Competitors

Competitors with Recent Insider Filings
Quest Diagnostics (N:DGX)
Chemed (N:CHE)
Select Medical Holdings (N:SEM)